Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Date:4/20/2011

than 25 percent during the quarter.
  • Filed a U.S. pre-market approval application with the FDA for the PROMUS Element Everolimus-Eluting Platinum Chromium Coronary Stent System, following positive PLATINUM clinical trial results.
  • Increased worldwide Neuromodulation sales 14 percent, Endoscopy sales 8 percent, Urology/Women's Health sales 5 percent and Peripheral Interventions (PI) sales 4 percent all on a constant currency basis, on the strength of new product introductions and continued adoption.
  • Continued to realign the product portfolio as part of the Company's POWER strategy, strengthening our PI franchise with the announcement of the acquisitions of S.I. Therapies and ReVascular Therapeutics.
  • Reduced gross debt obligations to $4.7 billion with prepayments of $500 million during the quarter and an additional $250 million of term loan debt in April.

  • “Despite an increasingly challenging U.S. CRM market and the resulting goodwill implications, we had several notable accomplishments during the quarter that illustrate progress toward the achievement of strategic milestones,” said Ray Elliott, President and Chief Executive Officer of Boston Scientific. “Our sales were at the high end of our projected range, we benefited from our cost-reduction initiatives, and we continue to aspire to double-digit EPS growth in the near term. Our increased financial flexibility has enabled us to reduce debt, expand our Emerging Markets footprint and complete six acquisitions in the past six months.”

    Net sales for the first quarter of 2011 were $1.925 billion, as compared to net sales of $1.960 billion for the first quarter of 2010, a decrease of 2 percent. Excluding the impact of foreign currency and sales from divested businesses, net sales decreased 1 percent as compared to the prior period.

    Worldwide CRM net sales for the first quarter - on a reported basis - were as follows:(in millions)U.S.Int
    '/>"/>

    SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
    2. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
    3. Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
    4. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
    5. Boston Scientific Announces Its ACC 2011 Schedule
    6. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
    7. Boston Scientific to Webcast Analyst Event
    8. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
    9. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
    10. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
    11. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... DALLAS , September 2, 2014 ... Chromatography Column Market by Type (Empty, Pre-packed, Analytical, Preparative), by Material ... Flash Chromatography, UFLC), TLC,SFC] - Forecast to 2018", published by ... Million in 2013. It is poised to grow at ... Million by 2018. Browse 90 market ...
    (Date:9/2/2014)... 2014 Particle Sciences, the leading CDMO for ... development and manufacturing capabilities with the addition of a ... Particle Sciences, Associate Director Clinical Production, "The company has ... square footage, equipment and staff across the board, all ... has over 6000ft 2 of operating cleanroom and ...
    (Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- Ortho Development® ... Alpine™ Hip Stem, the latest addition to its ... Stem is intended for use in total hip ... http://photos.prnewswire.com/prnh/20140830/141676 Alpine was ... stem philosophy. ODEV,s engineers worked closely with a ...
    Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2Ortho Development Receives FDA Clearance for Alpine Hip Stem 2
    ... 15 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ... to the pivotal Phase II trial of its lead ... novo poor-risk acute myelogenous leukemia (AML). Alan Kessman, ... reached this milestone in the pivotal Phase II trial ...
    ... Study to Explore the Efficacy of Novel Proteasome Inhibitor ... Patients with Relapsed and Refractory Multiple Myeloma, SOUTH ... Multiple Myeloma Research Consortium (MMRC) and Proteolix, Inc. today,announced ... Phase 2,clinical trial to study Proteolix,s potent and selective ...
    Cached Medicine Technology:Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4
    (Date:9/2/2014)... Illinois (PRWEB) September 02, 2014 ... Chief Executive Officer and Chief Information Officer Strategy ... Carlton Chicago. , Becker's Hospital Review Chief Executive ... together hospital and health system Chief Executive Officers, ... hospital and health system executives through high-quality ...
    (Date:9/2/2014)... FL (PRWEB) September 02, 2014 After respective performances ... compete against each other on September 5th at Sun Life Stadium. ... the brightest stars in the world of football in Colombian and ... some of the best talent in the world in early September. ... the world according to FIFA. The host nation of the ...
    (Date:9/2/2014)... (PRWEB) September 03, 2014 Recently, iFitDress.com, ... special occasion gowns, has released its range of 2014 ... are now offered at low prices. A large proportion ... the beautiful products from iFitDress.com are carefully made by ... it also offers bachelorette party gowns, ivory satin wedding ...
    (Date:9/2/2014)... BOSTON (September 2, 2014 4 pm EDT): In a ... American Medical Association , a team of Boston researchers ... improve dietary quality in the United States. The researchers ... at Tufts University, Harvard University and Boston Children,s Hospital ... subsidizing healthier foods could both help people make meaningful ...
    (Date:9/2/2014)... 2014 The exciting information sessions and ... Carey Lewis and Bob Wiley. The team ... who have the desire to illuminate entertainment with the ... could be invited to join the Bridge Training ... – Saturday, Sept. 6, Charlotte Convention Center, 501 South ...
    Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 2Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 3Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2
    ... , NORTH DARTMOUTH, Mass., Sept. 10 The ... is now offering all sleep medicine services at one location. ... the 84 Faunce Corner Road location in North Dartmouth, MA, ... their sleep disorders. , , While at ...
    ... , BALTIMORE, Sept. 10 The following statement ... Addiction Treatment Gap (CATG) initiative: , , ... addiction remains at pandemic levels, with 23 million Americans suffering from ... diabetes. But you wouldn,t know it from the way our ...
    ... , FORT LAUDERDALE, Fla., Sept. 10 ... on the dangers of synthetic hormone replacement therapy for menopausal women, ... safer treatment option. , , A white ... , published in the October edition of Life Extension ...
    ... NEW YORK, Sept. 10 Reportlinker.com announces that a new ... , North America Air Purification Equipment ... http://www.reportlinker.com/p0109900/North-America-Air-Purification-Equipment-Market.html , , ... Equipment in US$ Million & Thousand Units The market is ...
    ... SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: ... of technology and pharmacy benefit management (PBM) services, announced ... to June 30, 2011, for its informedRx PBM business ... Hawaii. Under the agreement, SXC is providing full-service PBM ...
    ... Sept. 10 Reportlinker.com announces that a new market research ... World Botulinum Toxin Market , ... This report analyzes the worldwide markets for Botulinum ... for ,Botulinum Toxin, by the Following Segments: Cosmetic, and Therapeutic ...
    Cached Medicine News:Health News:Sleep HealthCenters and Southcoast Hospitals Group Expand Patient Services in North Dartmouth 2Health News:Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA) 2Health News:Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA) 3Health News:The End of the Bio-Identical Hormone Debate 2Health News:Reportlinker Adds North America Air Purification Equipment Market Report 2Health News:Reportlinker Adds North America Air Purification Equipment Market Report 3Health News:Reportlinker Adds North America Air Purification Equipment Market Report 4Health News:Reportlinker Adds North America Air Purification Equipment Market Report 5Health News:Reportlinker Adds North America Air Purification Equipment Market Report 6Health News:Reportlinker Adds North America Air Purification Equipment Market Report 7Health News:Reportlinker Adds North America Air Purification Equipment Market Report 8Health News:Reportlinker Adds North America Air Purification Equipment Market Report 9Health News:Reportlinker Adds North America Air Purification Equipment Market Report 10Health News:Reportlinker Adds North America Air Purification Equipment Market Report 11Health News:Reportlinker Adds North America Air Purification Equipment Market Report 12Health News:Reportlinker Adds North America Air Purification Equipment Market Report 13Health News:Reportlinker Adds North America Air Purification Equipment Market Report 14Health News:Reportlinker Adds North America Air Purification Equipment Market Report 15Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 2Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 3Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 4Health News:Reportlinker Adds World Botulinum Toxin Market Report 2Health News:Reportlinker Adds World Botulinum Toxin Market Report 3Health News:Reportlinker Adds World Botulinum Toxin Market Report 4Health News:Reportlinker Adds World Botulinum Toxin Market Report 5Health News:Reportlinker Adds World Botulinum Toxin Market Report 6Health News:Reportlinker Adds World Botulinum Toxin Market Report 7Health News:Reportlinker Adds World Botulinum Toxin Market Report 8Health News:Reportlinker Adds World Botulinum Toxin Market Report 9Health News:Reportlinker Adds World Botulinum Toxin Market Report 10Health News:Reportlinker Adds World Botulinum Toxin Market Report 11Health News:Reportlinker Adds World Botulinum Toxin Market Report 12
    ... Lyra-i system combines the longest available wavelength ... maximize patient safety and efficacy. The unique ... the therapeutic range to all targeted structures. ... ensuring patient safety. All Lyra-I patients are ...
    ... The Company's Aura-i Laser System is ... designed for office-based procedures. Its unique, integrated ... benign vascular, including telangiectasia on the leg ... leg veins. It can also be used ...
    Surgisis Inguinal Hernia Matrix is implanted to reinforce soft tissues in the inguinal floor to repair inguinal hernias. Supplied sterile in peel-open packages. Intended for one-time use....
    Used for implantation to reinforce soft tissue in the repair of a hernia or body wall defect. Supplied sterile in peel-open packages. Intended for one-time use....
    Medicine Products: